ArticleSouth Asian journal of cancer2022

Ramucirumab in Indian Patients with Advanced Gastric Cancer-Does Borderline Performance Status and Heavy Burden of Disease in Real World Practice Impact Clinical Benefit?

Anant Ramaswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.